NCT01698138View on ClinicalTrials.gov

Prevention of Bladder Dysfunction in Acute Spinal Cord Injury

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

December 20, 2020

Study Completion Date

December 20, 2020

Conditions
Spinal Cord InjuriesUrinary Bladder, Overactive
Interventions
DRUG

Onabotulinumtoxin A

"30 transurethral injections, each of 1 ml solution containing 300 U Onabotulinumtoxin A (Botox ®, Allergan) in 30 ml of NaCl 0.9 %."

DRUG

Placebo

30 transurethral injections, each of 1 ml solution containing NaCl.

Trial Locations (2)

1450

Sunnaas Hospital, Nesoddtangen

0027

Oslo University Hospital, Oslo

All Listed Sponsors
collaborator

Sunnaas Rehabilitation Hospital

OTHER

lead

Oslo University Hospital

OTHER

NCT01698138 - Prevention of Bladder Dysfunction in Acute Spinal Cord Injury | Biotech Hunter | Biotech Hunter